Cargando…

Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps

Clinical specimens are each inherently unique, limited and non-renewable. As such, small samples such as tissue biopsies are often completely consumed after a limited number of analyses. Here we present a method that enables fast and reproducible conversion of a small amount of tissue (approximating...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Tiannan, Kouvonen, Petri, Koh, Ching Chiek, Gillet, Ludovic C, Wolski, Witold E, Röst, Hannes L, Rosenberger, George, Collins, Ben C, Blum, Lorenz C, Gillessen, Silke, Joerger, Markus, Jochum, Wolfram, Aebersold, Ruedi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390165/
https://www.ncbi.nlm.nih.gov/pubmed/25730263
http://dx.doi.org/10.1038/nm.3807
Descripción
Sumario:Clinical specimens are each inherently unique, limited and non-renewable. As such, small samples such as tissue biopsies are often completely consumed after a limited number of analyses. Here we present a method that enables fast and reproducible conversion of a small amount of tissue (approximating the quantity obtained by a biopsy) into a single, permanent digital file representing the mass spectrometry-measurable proteome of the sample. The method combines pressure cycling technology (PCT) and SWATH mass spectrometry (MS), and the resulting proteome maps can be analyzed, re-analyzed, compared and mined in silico to detect and quantify specific proteins across multiple samples. We used this method to process and convert 18 biopsy samples from 9 renal cell carcinoma patients into SWATH-MS fragment ion maps. From these proteome maps we detected and quantified more than 2,000 proteins with a high degree of reproducibility across all samples. The identified proteins clearly separated tumorous kidney tissues from healthy tissue, and differentiated distinct histomorphological kidney cancer subtypes.